Holen Sie sich die Stockscreener-App
0.528
5.16%
0.0259
Handel nachbörslich:
.53
0.002
+0.38%
Schlusskurs vom Vortag:
$0.5021
Offen:
$0.49
24-Stunden-Volumen:
10,000
Relative Volume:
1.77
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.63M
KGV:
-0.1158
EPS:
-4.5609
Netto-Cashflow:
$-20.20M
1W Leistung:
-1.31%
1M Leistung:
+5.12%
6M Leistung:
-96.15%
1J Leistung:
-98.07%
1-Tages-Spanne:
$0.47
$0.5282
1-Wochen-Bereich:
$0.47
$0.5288
52-Wochen-Spanne:
$0.46
$0.7499
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Firmenname
Reviva Pharmaceuticals Holdings Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare RVPH vs VRTX, REGN, MRNA, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.528 | 0 | 0 | -16.63M | -20.20M | -4.5609 |
VRTX
Vertex Pharmaceuticals Inc
|
514.99 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.90 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
182.56 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
963.79 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
368.08 | 39.20B | 5.76B | 514.49M | 1.10B | 4.4813 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-05 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-09-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-08 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2022-01-24 | Eingeleitet | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Aktie (RVPH) Neueste Nachrichten
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW) Peer Comparison – Compare with Others - Value Research
Reviva (RVPH) Earnings Snapshot: Profit Per Share Clears Its Benchmark in the Latest Reading; Market Move - vinanet.vn
Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) Stock Price, News & Analysis - Kalkine
Reviva (RVPH) Results Review: EPS Lands Above Forecast in Latest Trading; Share Response: Shares Move 8.70% HigherProfit Recovery Report - vinanet.vn
RVPH: Patent Filed for New Formulation - Yahoo Finance
Reviva Pharmaceuticals Holdings Stock Price Forecast. Should You Buy RVPH? - StockInvest.us
Reviva Pharmaceuticals Holdings, Inc. Stock (RVPH)Quote OTC Markets - marketscreener.com
OTC Market Listing Exposes Reviva Pharmaceuticals to Volatility, Illiquidity and Pricing Risks - TipRanks
Barclays PLC (RVPH) discloses 20-share beneficial stake in Reviva common stock - Stock Titan
Reviva Q2 loss narrows to $2.4m; EPS beats estimate - scanx.trade
Form 8K Reviva Pharmaceuticals Holdings, Inc. For: 12 August By Investing.com - Investing.com Nigeria
Reviva Q2 loss narrows as brilaroxazine milestones approach - Quiver Quantitative
Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times
Reviva Seeks Accelerated Patent Review for Drug Through 2046 - Stock Titan
RVPH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives 6.36% Stock AdvanceSpecial Dividend Alert - vinanet.vn
RVPH Q1 2026 Earnings: Narrower Loss Beats Estimates by 27.49%Product Revenue Analysis - vinanet.vn
Millennium entities (RVPH) disclose 1.07M-share, 8.2% Reviva Pharmaceuticals stake - Stock Titan
Reviva Pharmaceuticals (RVPH) Soars 17.47% to $0.47, Testing Key Resistance ZoneOvernight Profile - dars.gov.et
UBS Group (RVPH) exits Reviva Pharmaceuticals stake in updated report - Stock Titan
Reviva Pharmaceuticals (RVPH) Q1 2026 Earnings: Narrower Loss Surprises, Stock Dips on No Revenue Milestones - dars.gov.et
Reviva Pharmaceuticals Holdings Inc. (RVPH) Faces Steep Decline, Approaches Critical Support at $0.40Factor Crowding - dars.gov.et
RVPH Q1 2026 Earnings: Narrower Loss Surprises but Shares Slide on Pipeline UncertaintySaaS Earnings Trends - vinanet.vn
REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. Market Sentiment - Benzinga España
Reviva Pharmaceuticals Holdings, Inc. Revenue Breakdown – OTC:RVPH - TradingView
Reviva Pharmaceuticals (RVPH) Surges 11.9%: Key Levels and What Comes NextRisk Reversal - dars.gov.et
RVPH SEC FilingsREVIVA PHARMACEUTICALS HOLDINGS, INC. 10-K, 10-Q, 8-K Forms - Stock Titan
Operating margin % of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Delisting of Securities from The Nasdaq Stock Market - manilatimes.net
Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) — Files Form 25 to remove Common Stock from Nasdaq listing - Stock Titan
Reviva Pharmaceuticals Holdings (RVPH) Plunges 10% as Key Support NearsIV Expansion Alert - DonanımHaber
Reviva Pharmaceuticals (RVPH) Hovers Near Support Amid Minimal Price MovementDonchian Channel - dars.gov.et
Diluted earnings per share (diluted EPS) of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Enterprise value of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Price to earnings forward of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Enterprise value to EBIT forward of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH - TradingView
Reviva Pharmaceuticals (RVPH) Q1 2026 Earnings: Narrower Loss Exceeds Expectations as Pipeline Progress ContinuesDividend Growth Analysis - dars.gov.et
Reviva Pharmaceuticals Holdings, Inc. Actuals & Estimates (OTC:RVPH) - TradingView
RVPH Forecast — Price Target — Prediction for 2027 - TradingView
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing - The Manila Times
RVPH: Brilaroxazine shows strong efficacy, safety, and durability in schizophrenia, with NDA targeted for 2028 - TradingView
RVPH Q1 2026 Earnings: Narrower Loss Surprises but Stock DeclinesEarnings Cycle Outlook - Bölüm Sonu Canavarı
Reviva Pharmaceuticals to Present at the Life Sciences Investor Forum on June 24th - marketscreener.com
Reviva Pharmaceuticals (RVPH) Q1 2026 Earnings: EPS Surpasses Estimates as Pipeline Progress Offsets No RevenueStrong Earnings Momentum - po-news-eg.net
Reviva Pharmaceuticals Holdings Inc (RVPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Reviva Pharmaceuticals Holdings Inc (RVPHW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Reviva Pharmaceuticals Holdings Inc - TradingKey
Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.15%
Kapitalisierung:
|
Volumen (24h):